Volume 4, Number 11, September 2016
View or download the full issue PDF (ENG)
Editor's Welcome PDF (ENG)
Opportunities of new lipid-lowering therapy: proprotein convertase subtilisin/kexin type 9 inhibitors’ clinical efficacy and safety profile
Nevrez Koylan, Mamedov M.N.
Glycemic control in diabetes mellitus: review of international studies of glucose-lowering drugs cardiological safety
Akhmedova E.A., Dudinskaya E.N., Mardanov B.U., Abdalkina E.N., Kanorskii S.G.
Relationship between periodontal and cardiovascular diseases
Trukhan D.I., Trukhan L.Yu.
Estimation of atrial fibrillation risk development in patients with metabolic syndrome during atrial extrasystole registration
Olesin A.I., Litvinenko V.A., Shlapakova A.V., Konstantinova I.V.
Interrelation between statins and endothelial dysfunction marker in male and female patients with coronary atherosclerosis
Klimushina M.V., Gumanova N.G., Gorshkov A.Y., Gavrilova N.E., Metelskaya V.A.
Safety of chronic heart failure complex therapy: results of randomized crossover study BASTion
News from the European Society of Cardiology Congress 2016
Russian National Congress of Cardiology: main results